CLINICAL_TRIALS
trial_result
· 2021-03-22
Clinical Trial Update: Tanezumab in Osteoarthritis of the Knee [Phase 3]
Summary
Phase 3 trial update for tanezumab in knee osteoarthritis completed (results posted).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Arthritis, Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2021-03-22